Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Metropolitan Land Tbk. (MTLA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Metropolitan Land Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Metropolitan Land Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Metropolitan Land Tbk. trades at Rp535 (market cap 4.13T, 32.9K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Metropolitan Land Tbk. is far larger — about 24.9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (324K versus 32.9K). Which is the better fit depends on your goals.

MTLAOBAT
Market Cap
4.13T166.01B
Volume
32.9K324K
Lot
3293.24K
Turnover
17.14M77.68M
Average Price
520.88239.75
Value
17.14M77.68M
Indicative Equilibrium Price
530240
Indicative Equilibrium Volume
531

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MTLA
View details
OBAT
View details

About Metropolitan Land Tbk.

PT Metropolitan Land Tbk (the Company) was established within the framework of the Domestic Capital Investment Law No. 6 year 1968 as amenden by Law No. 12 year 1970 based on notarial deed No. 37 dated February 16, 1994 of Endang Irawati Ekaputri, S.H., Notary in Jakarta.

Read more on MTLA

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT